Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 478

    1.

    The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.

    Sellers TA, Mink PJ, Cerhan JR, Zheng W, Anderson KE, Kushi LH, Folsom AR.

    Ann Intern Med. 1997 Dec 1;127(11):973-80.PMID: 9412302 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.

    O'Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS.

    J Natl Cancer Inst. 2001 May 16;93(10):754-62.PMID: 11353785 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.

    Gapstur SM, Morrow M, Sellers TA.

    JAMA. 1999 Jun 9;281(22):2091-7.PMID: 10367819 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study.

    Pentti K, Honkanen R, Tuppurainen MT, Sandini L, Kröger H, Saarikoski S.

    Eur J Endocrinol. 2006 Jan;154(1):101-7.PMID: 16381998 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Postmenopausal hormone replacement therapy: scientific review.

    Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.

    JAMA. 2002 Aug 21;288(7):872-81. Review.PMID: 12186605 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Breast cancer and hormone-replacement therapy in the Million Women Study.

    Beral V; Million Women Study Collaborators.

    Lancet. 2003 Aug 9;362(9382):419-27. Erratum in: Lancet. 2003 Oct 4;362(9390):1160. PMID: 12927427 [PubMed - indexed for MEDLINE]Related articles

    8.

    Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy.

    Manjer J, Malina J, Berglund G, Bondeson L, Garne JP, Janzon L.

    Int J Cancer. 2001 Jun 15;92(6):919-22.PMID: 11351317 [PubMed - indexed for MEDLINE]Related articles

    9.

    Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

    Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ.

    JAMA. 2001 Mar 21;285(11):1460-5.PMID: 11255422 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.

    Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR.

    J Natl Cancer Inst. 2007 Jun 6;99(11):881-9.PMID: 17551148 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.
    12.

    Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.

    Tjønneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewertz M, Mellemkjaer L.

    Cancer. 2004 Jun 1;100(11):2328-37.PMID: 15160335 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.

    Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA.

    JAMA. 1995 Jul 12;274(2):137-42.PMID: 7596001 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hormone replacement therapy and breast cancer risk in a nationally representative cohort.

    Lando JF, Heck KE, Brett KM.

    Am J Prev Med. 1999 Oct;17(3):176-80.PMID: 10987632 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Estrogen replacement therapy and breast cancer]

    Bakken K, Alsaker E, Eggen AE, Lund E.

    Tidsskr Nor Laegeforen. 2005 Feb 3;125(3):282-5. Norwegian. PMID: 15702147 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

    Sourander L, Rajala T, Räihä I, Mäkinen J, Erkkola R, Helenius H.

    Lancet. 1998 Dec 19-26;352(9145):1965-9. Erratum in: Lancet 1999 Jan 23;353(9149):330. PMID: 9872245 [PubMed - indexed for MEDLINE]Related articles

    17.

    The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.

    Lemay A.

    J Obstet Gynaecol Can. 2002 Sep;24(9):711-5.PMID: 12360366 [PubMed - indexed for MEDLINE]Related articles

    18.

    Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase.

    Espié M, Daures JP, Chevallier T, Mares P, Micheletti MC, De Reilhac P.

    Gynecol Endocrinol. 2007 Jul;23(7):391-7.PMID: 17701770 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality.

    Durna EM, Wren BG, Heller GZ, Leader LR, Sjoblom P, Eden JA.

    Med J Aust. 2002 Oct 7;177(7):347-51.PMID: 12358575 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Factors modifying the association between hormone-replacement therapy and breast cancer risk.

    Pesch B, Ko Y, Brauch H, Hamann U, Harth V, Rabstein S, Pierl C, Fischer HP, Baisch C, Justenhoven C, Ranft U, Brüning T.

    Eur J Epidemiol. 2005;20(8):699-711.PMID: 16151884 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data